First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML
Clinical trial NCT04840784 · TERMINATED
Trial details
- NCT number
- NCT04840784
- Sponsor
- Shengke Pharmaceuticals Pty Ltd
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-29
- Primary completion
- 2023-05-02
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.